Lance Berman
Overview
Explore the profile of Lance Berman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
929
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Abbara A, Ufer M, Voors-Pette C, Berman L, Ezzati M, Wu R, et al.
Fertil Steril
. 2023 Nov;
121(1):95-106.
PMID: 37925096
Background: Kisspeptin is an essential regulator of hypothalamic gonadotropin-releasing hormone release and is required for physiological ovulation. Native kisspeptin-54 can induce oocyte maturation during in vitro fertilization treatment, including in...
2.
Jjingo C, Bala S, Waack U, Needles M, Bensman T, McMaster O, et al.
Clin Infect Dis
. 2023 Oct;
78(6):1564-1570.
PMID: 37802928
Allergic bronchopulmonary aspergillosis and invasive fungal diseases represent distinct infectious entities that cause significant morbidity and mortality. Currently, administered inhaled antifungal therapies are unapproved, have suboptimal efficacy, and are associated...
3.
Bailon L, Mothe B, Berman L, Brander C
Drugs
. 2020 Jun;
80(9):869.
PMID: 32495275
The first author currently listed as Lucia Bailon Alvarez should be Lucia Bailon.
4.
Bailon L, Mothe B, Berman L, Brander C
Drugs
. 2020 May;
80(9):859-868.
PMID: 32436069
Therapeutic approaches towards a functional cure or eradication of HIV have gained renewed momentum upon encouraging data emerging from studies in SIV monkey models and recent results from human clinical...
5.
Pitt B, Bakris G, Weir M, Freeman M, Lainscak M, Mayo M, et al.
ESC Heart Fail
. 2018 May;
5(4):592-602.
PMID: 29767459
Aims: Chronic kidney disease (CKD) in heart failure (HF) increases the risk of hyperkalaemia (HK), limiting angiotensin-converting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (ARB) use. Patiromer is a sodium-free,...
6.
Pitt B, Bushinsky D, Kitzman D, Ruschitzka F, Metra M, Filippatos G, et al.
ESC Heart Fail
. 2018 Jan;
5(3):257-266.
PMID: 29369537
Aims: Hyperkalaemia risk precludes optimal renin-angiotensin-aldosterone system inhibitor use in patients with heart failure (HF), particularly those with chronic kidney disease (CKD). Patiromer is a sodium-free, non-absorbed potassium (K )-binding...
7.
Weir M, Mayo M, Garza D, Arthur S, Berman L, Bushinsky D, et al.
J Hypertens
. 2017 Jan;
35 Suppl 1:S57-S63.
PMID: 28129247
Objective: Recurrent hyperkalemia frequently limits use of renin-angiotensin-aldosterone system inhibitors (RAASi) in chronic kidney disease (CKD) patients with hypertension, diabetes, and/or heart failure. Patiromer is a sodium-free, nonabsorbed potassium (K)-binding...
8.
Weir M, Bakris G, Gross C, Mayo M, Garza D, Stasiv Y, et al.
Kidney Int
. 2016 Jun;
90(3):696-704.
PMID: 27350174
Elevated serum aldosterone can be vasculotoxic and facilitate cardiorenal damage. Renin-angiotensin system inhibitors reduce serum aldosterone levels and/or block its effects but can cause hyperkalemia. Patiromer, a nonabsorbed potassium binder,...
9.
Zannad F, Rossignol P, Stough W, Epstein M, Alonso Garcia M, Bakris G, et al.
Int J Cardiol
. 2016 May;
216:46-51.
PMID: 27140336
Hyperkalemia is a common clinical problem, especially in patients with chronic kidney disease, diabetes mellitus, or heart failure. Treatment with renin angiotensin aldosterone system inhibitors exacerbates the risk of hyperkalemia...
10.
Li L, Harrison S, Cope M, Park C, Lee L, Salaymeh F, et al.
J Cardiovasc Pharmacol Ther
. 2016 Feb;
21(5):456-65.
PMID: 26856345
Hyperkalemia is a potentially life-threatening condition, and patients who have chronic kidney disease, who are diabetic, or who are taking renin-angiotensin-aldosterone system inhibitors are at increased risk. Therapeutic options for...